Search Within

Micaela Ariel Henrich

Formats
  1. Meeting Abstract (10)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (11)
  2. Breast Medicine Service (11)
  3. Department of Medicine (11)
  4. Epidemiology and Biostatistics (11)
  5. Solid Tumor Oncology Division (11)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)

More Groups

People
  1. Sujata Patil (8)
  2. Larry Norton (7)
  3. Christopher Barker (5)
  4. Stephen Solomon (5)
  5. Ayca Gucalp (4)
  6. Elizabeth Comen (4)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (3)
  4. 2018 (2)
  5. 2017 (3)
  6. 2016 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (3)
  3. Cancer Research (3)
  4. npj Breast Cancer (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (3)
  3. Oxford University Press (3)
  4. Nature Publishing Group (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases
    Journal Article

    Page, D. B.; Beal, K.; Linch, S. N.; Spinelli, K. J.; Rodine, M.; Halpenny, D.; Modi, S.; Patil, S.; Young, R. J.; Kaley, T.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Kallman, C.; D'Agnolo, A.; Rodine, M.; Arnold, B.; Zhang, Z. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Rodine, M.; Arnold, B.; Zhang, Z.; Ho, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer
    Meeting Abstract

    Ho, A.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B.; Patil, S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron Zapata, L.; Wen, Y. H.; Phung, A.; Wilgucki, M.; Henrich, M.; Arnold, B. B.; Zhang, Z.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)
    Meeting Abstract

    McArthur, H. L.; Beal, K.; Halpenny, D.; Henrich, M.; Patil, S.; Young, R.; Kaley, T.; Hamilton, N.; Hudis, C.; Wolchok, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save